STORY FROM: Drugs & Medical Devices

Annual 10-K Report Says Boston Scientific Conditionally Plans to Settle 50,000 Transvaginal Mesh Cases

MARLBOROUGH, Mass. — In its annual report filed with the U.S. Securities and Exchange Commission, Boston Scientific Corp. has announced that it has settled, or is in the process of settling, 50,000 of the 53,000 transvaginal mesh cases and claims against it.

According to its 10-K report for 2018, the master settlement agreements in principle provide that settlement “is conditional upon, among other things, achieving minimum required claimant participation thresholds.”

“Of the 50,000 cases and claims, 35,5000 have met the conditions of the settlement and are final,” the report says. “All settlement agreements were entered into solely by way ...

Associated Documents
Annual 10-K Report



Registered User Login

Username

Password

True